ALMDP — Medesis Pharma SA Balance Sheet
0.000.00%
- €1.80m
- €5.08m
Annual balance sheet for Medesis Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.075 | 0.065 | 2.89 | 0.255 | 0.042 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.325 | 0.376 | 0.778 | 0.935 | 1.16 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.392 | 0.591 | 3.79 | 1.37 | 1.53 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0.006 | 0.066 | 0.103 | 0.132 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.719 | 0.838 | 4.33 | 1.92 | 1.93 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.875 | 1.04 | 0.759 | 0.956 | 2.93 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.14 | 2.92 | 2.68 | 2.97 | 6.43 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.42 | -2.08 | 1.65 | -1.06 | -4.5 |
| Total Liabilities & Shareholders' Equity | 0.719 | 0.838 | 4.33 | 1.92 | 1.93 |
| Total Common Shares Outstanding |